GPT and Duchenne muscular dystrophy: Liver function was monitored primarily using glutamate dehydrogenase (GLDH) levels because standard tests for aspartate and alanine transaminases are unreliable indicators of liver function in the study population; these enzymes are present in muscle and typically elevated in patients with DMD, can be increased by activity and can be reduced after gene therapy treatment.